What is Promise Pharmacy as a company?

Promise Pharmacy is an independently owned 503A compounding pharmacy founded in 2006 and headquartered in Palm Harbor, Florida. It compounds patient-specific medications for clinic and telehealth partners with LegitScript certification and a unified provider portal at promisepharmacy.com.

Who owns Promise Pharmacy?

Promise Pharmacy describes itself as independently owned on its public about page and publishes a Patel-family leadership team including CEO Dee Patel, PharmD, and COO Amy Patel, RPh. Confirm the contracting legal entity — Promise Pharmacy LLC — during onboarding.

When was Promise Pharmacy founded?

Promise Pharmacy's public about page states the company was founded in 2006 and specializes in sterile and non-sterile 503A compounding for modern clinical care from its Palm Harbor, Florida facility.

How many clinics use Promise Pharmacy?

Promise Pharmacy's homepage claims 600+ clinic partners as of June 2026. That figure is a self-reported marketing claim on the public site — ask Promise directly for references from clinics with your therapy mix and volume rather than treating the headline number as audited fact.

What should I verify before signing with Promise Pharmacy?

Confirm active 503A licensure and LegitScript certification, that your patient states are actively licensed on the current map, wholesale rates on your top SKUs, COA and batch testing workflow, white-label minimums if applicable, and references from comparable clinics.

How does Fizy Health relate to Promise Pharmacy?

Fizy Health is an independent multi-partner ordering platform, not a compounder. It is not owned by or integrated with Promise Pharmacy — clinics may use Promise for Promise SKUs directly and evaluate Fizy Health separately for multi-partner batch checkout with pass-through pricing.

Promise Pharmacy company profile

Promise Pharmacy company profile: what is public, what to confirm

Promise Pharmacy is an independently owned 503A compounding pharmacy founded in 2006 and headquartered at 31818 US Hwy 19 N, Palm Harbor, Florida. It is LegitScript certified, publishes leadership names on its website, advertises service to 600+ clinics and 42 licensed states, and compounds patient-specific medications with third-party batch testing — but specific customer counts, revenue, and private funding details are marketing claims or undisclosed rather than independently audited on the public site.

If you are doing vendor due diligence on Promise Pharmacy as a company, this page separates the publicly verifiable facts from the details you should confirm directly — without filling gaps with guesses.

Compare Fizy Health vs Promise Pharmacy

Proudly Partnered With

What is publicly verifiable about Promise Pharmacy?

What can be verified from Promise Pharmacy's public materials is substantial for a compounding vendor: Promise Pharmacy LLC is an independently owned 503A compounding pharmacy founded in 2006 and based in Palm Harbor, Florida, reachable at promisepharmacy.com with contact at info@promisepharmacy.com and 727-772-0500. The site publishes leadership — including Dee Patel, PharmD (CEO), Amy Patel, RPh (COO), and other executive and partnership roles — LegitScript certification, USP 795/797/800 compliance claims, third-party potency and sterility testing with COA downloads per batch, a formulary of 200+ compounds, direct-to-patient shipping in 42 licensed states, provider partner and white-label programs, and a homepage claim of 600+ clinic partners. What is not independently verified on the public site includes audited customer counts, revenue, outside funding, and the precise on-time delivery percentage cited for enterprise partners — treat those as claims to confirm in diligence, not cited facts.

Who needs this profile

Due diligence falls to the people signing the provider agreement.

A company profile matters most to the roles responsible for vendor risk before a clinic commits to a compounding partner. Three of them carry that weight.

Owners
Founders accepting compounding vendor risk.
Owners sign the provider agreement and carry the risk of a pharmacy partner whose economics affect every cash-pay program. Their question is what can be confirmed about licensure, leadership stability, and wholesale pricing predictability — and what requires a direct ask.
Operators
Ops leads assessing fulfillment reliability.
Operations staff depend on 5-day fulfillment claims, COA access, and account manager responsiveness daily. They evaluate reliability through references, shipping performance in their licensed states, and portal workflow — not marketing statistics alone.
Prescribers
Providers confirming pharmacy legitimacy.
Prescribers want assurance Promise holds active 503A licensure, compounds under USP standards, and ships legally in each patient state. Their due diligence centers on LegitScript certification, batch testing documentation, and the current state shipping map.

What Promise publishes — and what to verify

Promise publishes more corporate detail than many B2B pharmacy vendors: founding year, headquarters address, named leadership, LegitScript certification, therapy categories, partner program structure, and a detailed state availability map showing licensed, pending, and unavailable jurisdictions. Several large states — including California, Texas, Minnesota, and others — are listed as unavailable on the public map as of June 2026, which matters directly for multi-state telehealth diligence.

Marketing claims such as 600+ clinic partners, a 98% on-time delivery rate, and a 4.8-star Google rating for patient care appear on public pages but are not accompanied by independent audit documentation on the site. Where a number is a self-reported marketing claim rather than a third-party verified statistic, this profile flags it for confirmation rather than repeating it as established fact.

What to ask Promise directly

Request the contracting legal entity (Promise Pharmacy LLC), confirmation of active 503A licensure and LegitScript certification in writing, and the current wholesale rate sheet for your top GLP-1 and hormone SKUs. Ask whether your patient states are actively licensed — not just listed on a marketing map — and for references from clinics with similar volume and therapy mix. Review white-label volume minimums, setup timeline (public pages cite 2–4 weeks), and cancellation terms if patient branding is part of the deal.

For comparison, Fizy Health is a different category — a multi-partner ordering platform, not a compounder — and publishes its model openly: pass-through per-vial 503A pricing before checkout, a disclosed facilitation fee, LegitScript-certified partners, and a BAA at onboarding. Clinics evaluating Promise for compounding may still evaluate Fizy Health separately if they batch refills across multiple assigned compounders.

After due diligence — which ordering model fits your clinic?

Promise Pharmacy fits if